Delve into the field of PARP inhibitors, a class that has gained traction in ovarian, breast, and prostate cancers.

AACR 2026 saw thousands gathered in San Diego, California, where major progress in cancer research was revealed.

Discover some of the new atopic dermatitis treatments in clinical development that could overcome existing challenges in the ...

Phage therapy is emerging as a potential solution to antibiotic resistance and superbugs, with clinical advances in ...

Discover what were the top biotech deals that were signed in March 2026. From small molecules to antibodies, M&A activity was high.

Delve into the pipeline strategy of major biotech Amgen, which is increasingly diversifying its growth engines.

Cell and gene therapies are moving towards correcting root causes of diseases. Let's take a look at future cell and gene therapy trends.

The ongoing controversy involving WuXi AppTec, a prominent Chinese pharmaceutical and biotechnology contract development and manufacturing organization (CDMO), has sent ripples through both ...

Small interfering RNA (siRNA) carries great promise in the biotechnology industry. As an essential component of the RNA interference (RNAi) pathway, siRNA works by degrading target messenger RNA (mRNA ...

AI has completely shifted the paradigm in the biotech industry. The past year has seen a gold rush in AI applications for the biopharma sector, for drug and protein discovery, or even treatment ...